Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

SG 209 is an analog of nicorandil and acts as a K+ channel opener and nitrate-free coronary vasodilator.

6-ethyl-7-hydroxy-4-methylchromen-2-one